Ulrike Nitz Selected Research

Ulrike Nitz Research Topics

Disease

56	Breast Neoplasms (Breast Cancer) 04/2024 - 10/2005
22	Neoplasms (Cancer) 12/2022 - 08/2006
5	Triple Negative Breast Neoplasms 11/2022 - 01/2020
5	Neoplasm Metastasis (Metastasis) 10/2021 - 08/2006
3	Pathologic Complete Response 10/2021 - 08/2013
3	Ovarian Neoplasms (Ovarian Cancer) 07/2011 - 09/2003
2	Infections 02/2021 - 01/2018
1	Lobular Carcinoma 04/2024
1	Febrile Neutropenia 02/2021
1	Neutropenia 02/2021
1	COVID-19 01/2020
1	Breast Carcinoma In Situ 01/2018
1	Alveolar Rhabdomyosarcoma 01/2018
1	Inflammation (Inflammations) 11/2015
1	Aneuploidy (Aneuploid) 04/2015
1	Circulating Neoplastic Cells 10/2013
1	Thrombosis (Thrombus) 07/2013
1	Spinal Cord Compression 12/2010
1	Meningeal Carcinomatosis 12/2010
1	Ovarian Epithelial Carcinoma 08/2006
1	Cardiotoxicity 10/2005

Drug/Important Bio-Agent (IBA)

11	Hormones (Hormone)IBA 12/2022 - 12/2009
6	Paclitaxel (Taxol)FDA LinkGeneric 01/2023 - 09/2003
6	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022 - 06/2010
6	Trastuzumab (Herceptin)FDA Link 01/2022 - 10/2005
5	AnthracyclinesIBA 01/2022 - 09/2009
4	Proteins (Proteins, Gene)FDA Link 04/2024 - 01/2007
4	Biomarkers (Surrogate Marker)IBA 01/2022 - 08/2013
4	taxaneIBA 01/2022 - 09/2009
4	human ERBB2 proteinIBA 01/2021 - 12/2009
4	Epirubicin (Ellence)FDA LinkGeneric 01/2019 - 06/2010
3	Aromatase InhibitorsIBA 12/2022 - 05/2013
3	Phenobarbital (Luminal)FDA Link 12/2021 - 01/2007
3	N-acetyltalosaminuronic acid (NAT)IBA 10/2021 - 01/2021
3	Carboplatin (JM8)FDA LinkGeneric 01/2020 - 09/2003
3	Docetaxel (Taxotere)FDA Link 01/2020 - 09/2009
2	Cadherins (E-Cadherin)IBA 04/2024 - 01/2022
2	Capecitabine (Xeloda)FDA Link 11/2023 - 01/2022
2	Tamoxifen FDA LinkGeneric 12/2022 - 12/2021
2	Estrogen ReceptorsIBA 12/2021 - 08/2016
2	Gemcitabine FDA Link 01/2020 - 01/2018
2	130-nm albumin-bound paclitaxelIBA 01/2020 - 01/2018
2	ErbB Receptors (EGF Receptor)IBA 01/2019 - 08/2016
2	Lapatinib (GW572016)FDA Link 01/2010 - 01/2008
1	IceIBA 11/2023
1	Ibandronic Acid (Boniva)FDA Link 11/2023
1	pertuzumabIBA 01/2022
1	Biological FactorsIBA 10/2021
1	pegfilgrastim (Neulasta)FDA Link 02/2021
1	Progesterone Receptors (Progesterone Receptor)IBA 11/2020
1	Transcription Factors (Transcription Factor)IBA 01/2018
1	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 08/2016
1	DNA (Deoxyribonucleic Acid)IBA 08/2016
1	Fluorouracil (Carac)FDA LinkGeneric 08/2016
1	Methotrexate (Mexate)FDA LinkGeneric 08/2016
1	Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric 08/2016
1	Ado-Trastuzumab EmtansineIBA 11/2015
1	Immunoconjugates (Immunoconjugate)IBA 11/2015
1	Tissue Inhibitor of MetalloproteinasesIBA 04/2015
1	Type II DNA Topoisomerases (Topoisomerase II)IBA 04/2015
1	Tissue Inhibitor of Metalloproteinase-1IBA 04/2015
1	Epoetin Alfa (Epogen)FDA Link 07/2013
1	Anastrozole (Arimidex)FDA LinkGeneric 05/2013
1	Peptides (Polypeptides)IBA 07/2011
1	Levonorgestrel (Plan B)FDA LinkGeneric 07/2011
1	Plasminogen Activator Inhibitor 1IBA 07/2011
1	Plasminogen InactivatorsIBA 07/2011
1	Therapeutic UsesIBA 07/2011
1	Tumor Biomarkers (Tumor Markers)IBA 07/2011
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 07/2011
1	Y-Box-Binding Protein 1IBA 12/2009
1	SteroidsIBA 12/2009
1	Taxoids (Taxanes)IBA 09/2009
1	ParaffinIBA 01/2007
1	Topotecan (Hycamtin)FDA LinkGeneric 08/2006
1	Monoclonal AntibodiesIBA 10/2005
1	Cisplatin (Platino)FDA LinkGeneric 09/2003

Therapy/Procedure

25	Drug Therapy (Chemotherapy) 11/2023 - 09/2003
21	Therapeutics 12/2022 - 10/2005
12	Adjuvant Chemotherapy 01/2022 - 10/2005
10	Neoadjuvant Therapy 11/2022 - 01/2008
2	Animal Assisted Therapy 12/2022 - 12/2021
2	Radiotherapy 10/2021 - 12/2010
2	Lymph Node Excision (Lymph Node Dissection) 08/2019 - 01/2019
1	Operative Surgical Procedures 10/2021
1	Mastectomy (Mammectomy) 08/2019
1	Adjuvant Radiotherapy 01/2019
1	Segmental Mastectomy (Lumpectomy) 01/2019
1	Drug Tapering 01/2018
1	Stem Cell Transplantation 08/2006
1	Induction Chemotherapy 08/2006